Acute myocardial infarction is one of the leading causes of death and disability globally, resulting from coronary plaque rupture or erosion with thrombotic occlusion. Timely reperfusion, via primary PCI or thrombolysis, remains the cornerstone of acute management, complemented by guideline-directed dual antiplatelet therapy, statins, and beta-blockade. Secondary prevention strategies targeting residual inflammation, plaque stabilisation, and optimal medication adherence are active research areas.
Loading articles...
